Sunpharma adv share price

• Stock Returns vs Nifty 100 Stock gave a 3 year return of 103.11% as compared to Nifty 100 which gave a return of 83.77%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated 103.11% return as compared to Nifty Pharma which gave investors 30.16% return over 3 year time period. (as of last trading session) NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x) 27.99 4.00 15.13 16.02 10.49 9.87 22.22 19.50 35.30 2.00 0.11 0.00 52.14 7.45 14.28 17.76 12.62 13.12 30.50 23.47 68.69 8.46 0.00 0.00 28.80 3.40 12.10 17.78 9.61 9.84 19.03 12.46 34.72 3.38 0.02 0.00 17.75 3.44 19.35 25.95 13.96 12.22 24.94 18.12 271.47 2.41 0.06 0.00 50.36 10.04 20.08 22.79 8.29 6.17 22.66 12.94 36.79 0.98 0.85 0.00 Add More • Stock Returns vs Nifty 100 Stock gave a 3 year return of 103.11% as compared to Nifty 100 which gave a return of 83.77%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated 103.11% return as compared to Nifty Pharma which gave investors 30.16% return over 3 year time period. (as of last trading session) Meeting Date Announced on Purpose Details May 26, 2023 May 11, 2023 Board Meeting Audited Results & Final Dividend Jan 31, 2023 Jan 16, 2023 Board Meeting Quarterly Results & Interim Dividend Nov 01, 2022 Oct 10, 2022 Board Meeting Quarterly Results Jul 29, 2022 Jul 12, 2022 Board Meeting Quarterly Results May 30, 2022 May 12, 2022 Board Meeting Audited R...

Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. We strive to build an enduring innovation engine built on strong scientific execution, high value analytics and aggressive portfolio management. A robust mix of internal ideation and strategic partnering with academic innovators and bio-pharma entrepreneurs fuel our engine with potentially high impact ideas. We partner with thought-leading clinicians across the world for ideas and access. Innovation through integration of partner knowledge and efficient internal execution shapes our future.

• 52 week High 265.75 • Traded Volume 20,832 • Traded Value (Cr) 0.40 • Avg. Traded Volume It is the average number of shares traded within a day in a given stock 19,181.27 • Avg.Traded Price -- • Face Value 1 • Dividend Yield 0 • Market Cap(Cr) 6224.32 • EPS 0 • Lower Circuit 153.45 • Upper Circuit 230.15 3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors. 5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Motilal Oswal Financial Services Limited. (MOFSL) Member of NSE, BSE, MCX, NCDEX - CIN no.: L67190MH2005PLC153397 Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022 - 71934200 / 71934263;Website Details of Compliance Officer: Name: Neeraj Agarwal, Email ID: C...